ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,877 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugIovance Biotherapeutics GmbH
Iovance Biotherapeutics GmbH Logo
Verified· 2 sources

Iovance Biotherapeutics GmbH

Summary

About the company

Iovance Biotherapeutics GmbH develops and investigates tumor‑infiltrating lymphocyte (TIL) therapies for the treatment of solid tumors. The company conducts preclinical and clinical research on T‑cell‑based immunotherapies, operates manufacturing capabilities and maintains a clinical pipeline and products shown on the website such as AMTAGVI (lifileucel) and Proleukin (aldesleukin).

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered5
Tumor-infiltrating lymphocyte therapy (TIL therapy)
Personalized cell therapy for the treatment of cancer with patient-specific TIL taken from the tumor, expanded outside the body, and administered once by reinfusion.
AMTAGVI (lifileucel)
Cell therapy for selected cancer indications, with product information, patient information, patient support, and country-specific monographs.
Proleukin (aldesleukin)
Medicinal product with product website, U.S. Prescribing Information, reporting points for adverse reactions and product quality complaints, as well as medical information by phone and email.
Manufacturing of TIL cell therapies
GMP-based manufacturing of patient-specific TIL cell therapies in the centralized Iovance Cell Therapy Center facility for commercial and clinical use.
Clinical TIL development
Development of TIL monotherapies and combination therapies in clinical trials for multiple solid tumors, including melanoma, NSCLC, gynecologic tumors and other indications.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Knowledge

No knowledge articles yet

Once Iovance Biotherapeutics GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Iovance Biotherapeutics GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Iovance Biotherapeutics GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Iovance Biotherapeutics GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Gubelstrasse 11
6300 Zug

At a glance

Legal form
Limited Liability Company
UID
CHE-288.357.577
Founded
2021 · 5 years
Last commercial register change
November 3, 2021
Employees
11 to 20

Similar companies

BA
Bioeq AG
Zug
BG
BioGntx Global R&D GmbH
Zug
A(
Amgen (Europe) GmbH
Rotkreuz
VA
Vesifact AG
Baar